MX390386B - Carotenoides microbianos que afectan la composicion de la microbiota intestinal - Google Patents

Carotenoides microbianos que afectan la composicion de la microbiota intestinal

Info

Publication number
MX390386B
MX390386B MX2018016118A MX2018016118A MX390386B MX 390386 B MX390386 B MX 390386B MX 2018016118 A MX2018016118 A MX 2018016118A MX 2018016118 A MX2018016118 A MX 2018016118A MX 390386 B MX390386 B MX 390386B
Authority
MX
Mexico
Prior art keywords
composition
microbial
compound
affect
carotenoids
Prior art date
Application number
MX2018016118A
Other languages
English (en)
Spanish (es)
Other versions
MX2018016118A (es
Inventor
Cindy Duysburgh
Iris Pinheiro
Massimo Marzorati
Den Abbeele Pieter Van
Sam Possemiers
Selin Bolca
Original Assignee
Microbial Res Management Health Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Res Management Health Nv filed Critical Microbial Res Management Health Nv
Publication of MX2018016118A publication Critical patent/MX2018016118A/es
Publication of MX390386B publication Critical patent/MX390386B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MX2018016118A 2016-06-22 2017-06-22 Carotenoides microbianos que afectan la composicion de la microbiota intestinal MX390386B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16175832 2016-06-22
PCT/EP2017/065348 WO2017220708A1 (en) 2016-06-22 2017-06-22 Microbial carotenoids affecting gut microbial composition

Publications (2)

Publication Number Publication Date
MX2018016118A MX2018016118A (es) 2019-07-08
MX390386B true MX390386B (es) 2025-03-20

Family

ID=56203217

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018016118A MX390386B (es) 2016-06-22 2017-06-22 Carotenoides microbianos que afectan la composicion de la microbiota intestinal

Country Status (12)

Country Link
US (1) US11324717B2 (enExample)
EP (1) EP3474862B1 (enExample)
JP (1) JP6966543B2 (enExample)
KR (1) KR102413408B1 (enExample)
CN (1) CN109641006B (enExample)
AU (1) AU2017281589B2 (enExample)
BR (1) BR112018076485A8 (enExample)
CA (1) CA3028031C (enExample)
IL (1) IL263683B (enExample)
MX (1) MX390386B (enExample)
RU (1) RU2759600C2 (enExample)
WO (1) WO2017220708A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114949001A (zh) 2012-08-29 2022-08-30 加州理工学院 孤独症谱系障碍的诊断和治疗
US10124025B2 (en) 2014-10-30 2018-11-13 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
KR20170086492A (ko) 2014-10-30 2017-07-26 캘리포니아 인스티튜트 오브 테크놀로지 신경발달 장애에서의 행동을 개선시키기 위한 박테리아를 포함하는 조성물 및 방법
KR20190127710A (ko) * 2017-02-07 2019-11-13 캘리포니아 인스티튜트 오브 테크놀로지 헌팅톤병 및 레트 증후군에서의 장 미생물총의 조정
MX2020005875A (es) 2017-12-05 2020-10-08 Bioplx Inc Métodos y composiciones para prevenir la infección microbiana.
WO2020043797A1 (en) * 2018-08-29 2020-03-05 Dsm Ip Assets B.V. Formulations for improving gut health
CN110283754B (zh) * 2019-07-11 2021-02-02 中国科学院北京基因组研究所 用于类风湿关节炎炎症状态评估及预后评价的肠道微生物菌群
KR102369996B1 (ko) * 2020-04-21 2022-03-02 박선민 대사성 질환과 안질환의 예방 및 건강 유지를 위한 장내 미생물 검사 기반 맞춤형 프리바이오틱스 또는 프로바이오틱스 정보 제공방법
CN115606802A (zh) * 2022-10-21 2023-01-17 中国农业大学 番茄红素在制备修复肠屏障损伤的产品中的应用
WO2025262090A1 (en) 2024-06-18 2025-12-26 Dsm Ip Assets B.V. Combination of carotenoids and inulin and uses thereof
CN119184223A (zh) * 2024-10-14 2024-12-27 元医(杭州)科技有限公司 一种基于耐辐射奇球菌素的功能宠物食品及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ560386A (en) * 2005-01-31 2009-12-24 Mylan Lab Inc Pharmaceutical composition comprising hydroxylated nebivolol
GB0524873D0 (en) * 2005-12-06 2006-01-11 New Royal Holloway & Bedford Bacterial production of carotenoids
GB201013041D0 (en) 2010-08-03 2010-09-15 Royal Holloway & New Bedford College Carotenoids

Also Published As

Publication number Publication date
RU2019101481A3 (enExample) 2020-10-16
BR112018076485A2 (pt) 2019-04-09
JP2019524877A (ja) 2019-09-05
IL263683B (en) 2022-04-01
KR20190039687A (ko) 2019-04-15
US20190209516A1 (en) 2019-07-11
US11324717B2 (en) 2022-05-10
KR102413408B1 (ko) 2022-06-27
RU2759600C2 (ru) 2021-11-16
BR112018076485A8 (pt) 2022-12-06
MX2018016118A (es) 2019-07-08
WO2017220708A1 (en) 2017-12-28
CA3028031C (en) 2023-02-28
JP6966543B2 (ja) 2021-11-17
RU2019101481A (ru) 2020-07-22
CN109641006A (zh) 2019-04-16
EP3474862A1 (en) 2019-05-01
CN109641006B (zh) 2022-07-01
AU2017281589A1 (en) 2019-01-31
CA3028031A1 (en) 2017-12-28
EP3474862B1 (en) 2025-10-29
AU2017281589B2 (en) 2023-03-23
IL263683A (en) 2019-01-31

Similar Documents

Publication Publication Date Title
MX2018016118A (es) Carotenoides microbianos que afectan la composicion de la microbiota intestinal.
EA201992878A1 (ru) Соединения для лечения болезни хантингтона
BR112018014222A2 (pt) método de tratamento da glomerulopatia c3
BR112018004620A2 (pt) moduladores da expressão de kras
MX391850B (es) Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington
BR112017003658A2 (pt) composto, mistura, métodos para tratamento de uma doença e para inibição de uma glicosidase, e, composição farmacêutica.
MX2019009861A (es) Composiciones farmaceuticas de un derivado de acido biliar y microbioma y usos de las mismas.
WO2016060996A3 (en) Interleukin-15 compositions and uses thereof
BR112018013174A2 (pt) composição e método para crescimento de cabelo
BR112015022545A2 (pt) compostos de pirazolo e os usos disso
BR112014004444A2 (pt) composições e métodos que compreendem uma variante de enzima lipolítica
BR112014014410A2 (pt) composições e métodos que compreendem uma variante de enzima lipolítica
BR112015022340A2 (pt) método para tratamento ou prevenção de uma doença ou distúrbio relacionado à calicreína em um sujeito, composto, e, composição farmacêutica
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
EA202090683A2 (ru) Способы и композиции для лечения рака
BR112019000849A2 (pt) composições líquidas de limpeza com sistema antibacteriano e método de fabricação das mesmas
BR112017000024A2 (pt) composição para tratamento de tecidos que compreende uma nanoemulsão polimérica de aminossiloxano
MX2018007124A (es) Mezcla de hmo.
NZ748769A (en) Nitroxyl donors with improved therapeutic index
HK1257296A1 (zh) 新的化合物及其用途
EP4327876A3 (en) Immunogenic compositions
PH12016501988A1 (en) Antibacterial compounds
BR112017016084A2 (pt) composição e método para o tratamento da doença veno-oclusiva hepática
MY191930A (en) Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease
BR112017013845A2 (pt) derivados de glucagon